izpis_h1_title_alt

The evolving role of microsampling in therapeutic drug monitoring of monoclonal antibodies in inflammatory diseases
ID Mingas, Panagiotis-Dimitrios (Author), ID Zdovc, Jurij (Author), ID Grabnar, Iztok (Author), ID Vovk, Tomaž (Author)

.pdfPDF - Presentation file, Download (959,28 KB)
MD5: F2A67BF7B3E2B53EFEFD3887AC13A419
URLURL - Source URL, Visit https://www.mdpi.com/1420-3049/26/6/1787 This link opens in a new window

Abstract
Monoclonal antibodies (mAbs) have been extensively developed over the past few years, for the treatment of various inflammatory diseases. They are large molecules characterized by complex pharmacokinetic and pharmacodynamic properties. Therapeutic drug monitoring (TDM) is routinely implemented in the therapy with mAbs, to monitor patients’ treatment response and to further guide dose adjustments. Serum has been the matrix of choice in the TDM of mAbs and its sampling requires the visit of the patients to laboratories that are not always easily accessible. Therefore, dried blood spots (DBS) and various microsampling techniques have been suggested as an alternative. DBS is a sampling technique in which capillary blood is deposited on a special filter paper. It is a relatively simple procedure, and the patients can perform the home-sampling. The convenience it offers has enabled its use in the quantification of small-molecule drugs, whilst in the recent years, studies aimed to develop microsampling methods that will facilitate the TDM of mAbs. Nevertheless, hematocrit still remains an obstacle that hinders a more widespread implementation of DBS in clinical practice. The introduction of novel analytical techniques and contemporary microsampling devices can be considered the steppingstone to the attempts made addressing this issue.

Language:English
Keywords:microsampling, DBS, VAMS, mAbs, TDM, inflammatory diseases
Work type:Article
Typology:1.02 - Review Article
Organization:FFA - Faculty of Pharmacy
Publication status:Published
Publication version:Version of Record
Year:2021
Number of pages:19 str.
Numbering:Vol. 26, iss. 6, art. 1787
PID:20.500.12556/RUL-135187 This link opens in a new window
UDC:616-002:616.1/.9
ISSN on article:1420-3049
DOI:10.3390/molecules26061787 This link opens in a new window
COBISS.SI-ID:56889347 This link opens in a new window
Publication date in RUL:28.02.2022
Views:401
Downloads:81
Metadata:XML RDF-CHPDL DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Molecules
Shortened title:Molecules
Publisher:MDPI
ISSN:1420-3049
COBISS.SI-ID:18462981 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:22.03.2021

Secondary language

Language:Slovenian
Keywords:vnetje, bolezni

Projects

Funder:ARRS - Slovenian Research Agency
Project number:P1-0189
Name:Farmacevtska tehnologija: od dostavnih sistemov učinkovin do terapijskih izidov zdravil pri otrocih in starostnikih

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back